Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Cell Carrier
100%
Interferon-α (IFN-α)
100%
Blood Outgrowth Endothelial Cells
100%
Oncolytic Vesicular Stomatitis Virus
100%
Lung
11%
Clinical Translation
11%
Tumor Model
11%
Syngeneic
11%
Antitumor Activity
11%
Antiviral Immunity
11%
Human Donor
11%
Effective Strategies
11%
Metastatic Lung Cancer
11%
Oncolytic Virotherapy
11%
Lung Tumor
11%
Metastatic Non-small Cell Lung Cancer
11%
Oncolytic Virus
11%
Viral Therapy
11%
Human Blood
11%
Systemic Administration
11%
Tumor Burden
11%
Non-small Cell Lung Cancer Cells
11%
A549 Xenograft
11%
Xenograft Model
11%
Mouse Serum
11%
Antibody Neutralization
11%
Complement Immunity
11%
Oncolytic VSV
11%
Medicine and Dentistry
Endothelial Cell
100%
Non Small Cell Lung Cancer
100%
Interferon
100%
Vesiculovirus
100%
Ex Vivo
11%
Lung
11%
In Vitro
11%
Cancer Cell
11%
Lung Cancer
11%
Neoplasm
11%
Lung Tumor
11%
Tumor Model
11%
Immunity
11%
Xenograft
11%
Antiviral Immunity
11%
Systemic Administration
11%
Antineoplastic Activity
11%
Oncolytic Virotherapy
11%
Neutralizing Antibody
11%
Virotherapy
11%
Oncolytic Virus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Interferon
100%
Vesiculovirus
100%
Virotherapy
22%
Mouse Model
11%
Antitumor Activity
11%
Murine
11%
Antivirus Agent
11%
Tumor Model
11%
Lung Tumor
11%
Lung Cancer
11%
Oncolytic Virus
11%
Systemic Administration
11%
Neoplasm
11%
Neutralizing Antibody
11%
Immunology and Microbiology
Interferon Type I
100%
Vesiculovirus
100%
Virotherapy
22%
Xenograft
11%
Neutralizing Antibody
11%
Antiviral Immunity
11%
Oncolytic Virus
11%
Mouse Model
11%
Antineoplastic Activity
11%
Syngenic
11%
Immunity
11%
Cancer Cell
11%
Murine
11%
Tumor Volume
11%